Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3664-3668

  Ahmadian, Mohsen ^a   Wistuba, Ignacio I ^a,c   Fong, Kwun M ^a   Behrens, Carmen ^a   Kodagoda, Dulmini R ^a   Saboorian, M Hossein ^b   Shay, Jerry ^a   Tomlinson, Gail E ^a,b   Blum, Joanne ^d   Minna, John D ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; EXON; FAMILIAL DISEASE; GENE DELETION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; POINT MUTATION; PRIORITY JOURNAL; SILENCER GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 3; FAMILY; FEMALE; GENE DELETION; HUMANS; NEOPLASM PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; PROTEINS;

EID: 15644367677     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bieche, I., and Lidereau, R. Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14: 227-251, 1995.
2. Cox, L. A., Chen, G., and Lee, E. Y. Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res. Treat., 32: 19-38, 1994.
3. Devilee, P., and Cornelisse, C. J. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198: 113-130, 1994.
4. Callahan, R., Gallahan, D., Smith, G., Cropp, C., Merlo, G., Diella, F., Liscia, D., and Lidereau, R. Frequent mutations in breast cancer. Ann. NY Acad. Sci., 698: 21-30, 1993.
5. Chen, L. C., Matsumura, K., Deng, G., Kurisu, W., Ljung, B. M., Lerman, M. I., Waldman, F. M., and Smith, H. S. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res., 54: 3021-3024, 1994.
6. Devilee, P., van den Broek, M., Kuipers-Dijkshoorn, N., Kolluri, R., Khan, P. M., Pearson, P. L., and Cornelisse, C. J. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics, 5: 554-560, 1989.
7. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
8. Thiagalingam, S., Lisitsyn, N. A., Hamaguchi, M., Wigler, M. H., Willson, J. K., Markowitz, S. D., Leach, F. S., Kinzler, K. W., and Vogelstein, B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res., 56: 2936-2939, 1996.
9. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
10. Panagopoulos, I., Pandis, N., Thelin, S., Petersson, C., Mertens, F., Borg, A., Kristoffersson, U., Mitelman, F., and Aman, P. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res., 56: 4871-4875, 1996.
11. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
12. Wistuba, I. I., Montellano, F. D., Milchgrub, S., Virmani, A. K., Behrens, C., Chen, H., Ahmadian, M., Novak, J., Muller, C., Minna, J. D., and Gazdar, A. F. Deletion of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res., 57: 3154-3158, 1997.
13. Druck, T., Hadaczek, P., Fu, T. B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
14. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian., M., Tiong Ong, S., Rassool, F. V., Zimmerman, P. V., Giaccone, G., Gazdar, A. F., and Minna, J. D. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res., 57: 2256-2267, 1997.
15. Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (Washington DC), 274: 2057-2059, 1996.
16. Man, S., Ellis, I., Sibbering, R., Blarney, R., and Brook, D. High levels of allele loss at FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res., 56: 5484-5489, 1996.
17. Wilke, C., Hall, B., Hoge, A., Pardee, W., Smith, D., and Glover, T. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-196, 1996.
18. Zimonjic, D., Druck, T., Ohta, M., Kastury, K., Croce, C., Popescu, N., and Huebner, K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res., 57: 1166-1170, 1997.
19. Mao, L., Fan, Y. H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
20. Barnes, L. D., Garrison, P. N., Siprashvili, Z., Guranowski, A., Robinson, A. K., Ingram, S. W., Croce, C. M., Ohta, M., and Huebner, K. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-P1,P3-triphosphate hydrolase. Biochemistry, 35: 11529-11535, 1996.
21. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E. F., Roche, J., Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger, H., and Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet., 6: 193-203, 1997.